美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Alpha Cognition Inc.

0.3500

0.0000

成交量：- -

成交額：- -

市值：211.20萬

市盈率：-0.89

高：0.3500

開：0.3500

低：0.3500

收：0.3500

資料載入中...

總覽公司新聞公告

公司資料

公司名字：

Alpha Cognition Inc.

交易所：

OTCQB

成立時間：

- -

員工人數：

- -

公司地址：

- -

官網：

http://www.alphacognition.com

郵編：

- -

電話：

- -

傳真：

- -

簡介：

Alpha Cognition Inc.於2017年11月15日根據《不列顛哥倫比亞省商業公司法》（“BCBCA”）成立，名稱為“Crystal Bridge Enterprises Inc.”，為加拿大資本聯營公司。他們於2021年3月18日完成了與Alpha Cognition Canada Inc.的合格交易，並將其名稱更改為Alpha Cogning股份有限公司。Alpha Cognition, Inc.是一家商業化前階段的生物製藥公司，致力於為阿爾茨海默病等神經退行性疾病患者開發治療方法。

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/ACOGF/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ACOGF","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ACOGF\",,,,,undefined,":{"symbol":"ACOGF","market":"US","secType":"STK","nameCN":"Alpha Cognition Inc.","latestPrice":0.35,"timestamp":1750449600000,"preClose":0.35,"halted":0,"volume":0,"delay":15,"floatShares":5977591,"shares":6034221,"eps":-0.39186,"marketStatus":"休市中","change":0,"latestTime":"06-20 16:00:00 EDT 延時","open":0.35,"high":0.35,"low":0.35,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.39186,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1750665600000},"marketStatusCode":7,"adr":0,"exchange":"OTCQB","adjPreClose":0.35,"volumeRatio":1.6728741919903694},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ACOGF\",,,,,undefined,":{"symbol":"ACOGF","floatShares":5977591,"roa":"-374.07%","roe":"-2256.67%","lyrEps":-0.134681,"volumeRatio":1.6728741919903694,"shares":6034221,"dividePrice":0,"high":0.35,"amplitude":0,"preClose":0.35,"low":0.35,"week52Low":0.35,"pbRate":"-1.52","week52High":17.0862,"institutionHeld":0,"latestPrice":0.35,"eps":-0.39186,"divideRate":0,"volume":0,"delay":15,"ttmEps":-0.39186,"open":0.35,"prevYearClose":0.35,"prevWeekClose":0.35,"prevMonthClose":0.35,"prevQuarterClose":0.35,"fiveDayClose":0.35,"twentyDayClose":0.35,"sixtyDayClose":0.35},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.alphacognition.com","description":"Alpha Cognition Inc.於2017年11月15日根據《不列顛哥倫比亞省商業公司法》（“BCBCA”）成立，名稱為“Crystal Bridge Enterprises Inc.”，為加拿大資本聯營公司。他們於2021年3月18日完成了與Alpha Cognition Canada Inc.的合格交易，並將其名稱更改為Alpha Cogning股份有限公司。Alpha Cognition, Inc.是一家商業化前階段的生物製藥公司，致力於為阿爾茨海默病等神經退行性疾病患者開發治療方法。","exchange":"OTCQB","name":"Alpha Cognition Inc.","nameEN":"Alpha Cognition Inc."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"ACOGF\",market:\"US\",,,undefined,":null,"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ACOGF\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-11-05","symbol":"ACOGF","defaultRemindTime":1730817000000,"type":"split","dateTimestamp":1730782800000,"forFactor":25,"toFactor":1,"ratio":25}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ACOGF\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ACOGF\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1721365200000}}}